Godwin Mary E.

Track

Insider profile

Performance

Overall performance
3.2
Performance over holding periods
3.2
30 days 90 days 120 days
Average return 2% 8.2% 15.1%
Success rate 57% 68% 82%
Transactions
2 0% Buy
34 71% Buy
47 69% Buy
Ranking by holding-period performance
Godwin Mary E.'s trades of Nautilus Biotechnology, Inc.'s stock


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Transaction date
Proposed sale
Price
371.51
Quantity 60,805
Value US$4,452,431
Transaction date
Proposed sale
Price
190.15
Quantity 36,314
Value US$4,973,075
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value 		Number of shares Price Value Details
2024-12-17 2024-12-17
PrS Proposed sale
60,805
371.51
US$4,452,431 		60,805 371.51 US$4,452,431
2024-12-09 2024-12-09
PrS Proposed sale
36,314
190.15
US$4,973,075 		36,314 190.15 US$4,973,075
2024-12-03 2024-12-03
PrS Proposed sale
90,465
458.01
US$820,800 		90,465 458.01 US$820,800
2024-11-26 2024-11-26
PrS Proposed sale
60,000
2.28
US$136,512 		60,000 2.28 US$136,512
2024-11-21 2024-11-21
PrS Proposed sale
30,000
2.35
US$70,623 		30,000 2.35 US$70,623
2024-11-19 2024-11-19
PrS Proposed sale
30,000
2.27
US$68,046 		30,000 2.27 US$68,046
2024-11-12 2024-11-11
PrS Proposed sale
40,000
2.47
US$98,884 		40,000 2.47 US$98,884
2024-11-08 2024-11-08
PrS Proposed sale
31,078
2.51
US$78,158 		31,078 2.51 US$78,158
2024-11-07 2024-11-07
PrS Proposed sale
28,922
2.75
US$79,643 		28,922 2.75 US$79,643
2024-09-25 2024-09-23
S Sale
47,031 -100.0%
2.87
US$134,744 		47,031 -100.0% 2.87 US$134,744
2024-09-23 2024-09-23
PrS Proposed sale
47,031
2.86
US$134,739 		47,031 2.86 US$134,739
2024-09-18 2024-09-17
S Sale
35,000 -100.0%
2.85
US$99,869 		35,000 -100.0% 2.85 US$99,869
2024-09-17 2024-09-17
PrS Proposed sale
35,000
2.85
US$99,866 		35,000 2.85 US$99,866